Evaluating the Management of Cancer Immunotherapy (CIT): Roundtable Discussion
Exclusive Coverage of the 2021 American Academy of Allergy, Asthma & Immunology Virtual Annual Meeting
Implications of Oral Therapy in Metastatic Breast Cancer: Considerations for Delivery Networks
Exclusive Coverage of the Academy of Managed Care Pharmacy Nexus 2021 Meeting
Coverage of the Academy of Managed Care Pharmacy Nexus 2021 Meeting, which took place in a hybrid format.
The Effect of Evolving Treatment Options on the Management of Multiple Myeloma
The Evolving Role of Immunotherapies in the Treatment of Cervical Cancer
Examining Developments in Multicancer Early Detection: Highlights of New Clinical Data from Recent Conferences
Volume: 27
Issue: 19
Patients With Diabetes and Chronic Kidney Disease: ACE Inhibitor or ARB Treatment, Medical Costs for Disease Management, and the FINE-CKD Model to Evaluate Economic Value of Finerenone
Issue: 20
Exclusive Coverage of the European Society of Cardiology 2021 Congress
Coverage of the European Society of Cardiology 2021 Congress, which took place in a virtual format.
Inhaled Treprostinil in Pulmonary Hypertension Due to Interstitial Lung Disease
Oncology-Centric Biosimilar Implementation at M Health Fairview: A Review of Process and Perspective
Assessing the Impact of Immunotherapy on Quality of Life and Patient Outcomes in the Frontline Management of Advanced Non−Small Cell Lung Cancer
Examining Unmet Needs in the Management of Eosinophilic Esophagitis
Population Health Implications of Cardiorenal Metabolic Syndrome
Exclusive Coverage of the European Society for Medical Oncology 2021 Congress
Highlights from the European Society of Medical Oncology 2021 Congress, which took place September 16-21, 2021, in a virtual format.
Strategies for Effective Cardiovascular Risk Management Through Lipid Management: A Transitional Approach From Hospital to Home
Benefit of Prompt Versus Delayed Initiation of Single-Inhaler Triple Therapy on Exacerbations and Healthcare Costs Among Patients with Chronic Obstructive Pulmonary Disease in the US
Innovative Enhanced Medication Therapy Management Model: MedWise Risk Score, Medication Safety Review, and Health Care Outcomes
Issue: 16
Antineutrophil Cytoplasmic Antibody (ANCA) Vasculitis: Pathophysiology, Diagnosis, and the Evolving Treatment Landscape
Issue: 15
Optimizing the Value of CAR T-Cell Therapy: Managed Care Considerations From Recent Clinical Findings
Issue: 13
Addressing the Role of Edaravone in the Management of Amyotrophic Lateral Sclerosis and Gaps in Care and Access: Expert Panel Recommendations
Issue: 12
Profiles in Care: Importance of a Coordinated Health Care Plan in Plaque Psoriasis and Psoriatic Arthritis Management
Utilizing Oncology Biosimilars to Minimize the Economic Burden Associated With Cancer Treatment: Managed Care Considerations
Volume: 26
Issue: 14
MS Stakeholder Summit: New Treatment Landscape in Multiple Sclerosis (MS)—Preventing Long-Term Disability Through High-Efficacy Treatments in Early MS
AJMC® Roundtable: Defining Value for the Treatment of Brain Metastases in HER2+ Metastatic Breast Cancer
The Effect of Antibiotic Resistance on the Management of Helicobacter pylori Infection
Evolving Evidence-Based Treatment Guidelines for Iron Deficiency Anemia in Inflammatory Bowel Disease: Considerations in Managed Care
Issue: 11
Outcomes-Based Agreements Give New Insight for Treatment of Diabetes and Cardiovascular Disease
New Horizons in the Treatment of Basal Cell Carcinoma
The Role of Real-world Evidence in the Evolving Treatment Landscape of Multiple Myeloma
